Hostname: page-component-7479d7b7d-qlrfm Total loading time: 0 Render date: 2024-07-12T09:42:45.358Z Has data issue: false hasContentIssue false

Non-Motor Symptoms and Parkinsonism

Published online by Cambridge University Press:  23 September 2014

Oksana Suchowersky*
Affiliation:
University of Alberta, Edmonton, Alberta, Canada
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Copyright
Copyright © The Canadian Journal of Neurological 2013

References

1. Rajput, AH. Levodopa prolongs life expectancy and is non-toxic to substantia nigra. Parkinsonism Relat Disord. 2001;8:95100.CrossRefGoogle ScholarPubMed
2. Chaudhuri, KR, Healy, DG, Schapira, AH. Non-motor symptoms of Parkinson disease: diagnosis and management. Lancet Neurol. 2006;5:235–45.Google Scholar
3. Marinez-Martin, P, Schapira, AH, Stocchi, R, et al. Prevalence of nonmotor symptoms in Parkinson disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord. 2007;22:1623–9.Google Scholar
4. Shulman, LM, Taback, RL, Rabinstein, AA, et al. Non-recognition of depression and other non-motor symptoms in Parkinson disease. Parkinson Relat Disord. 2002;8:193–7.Google Scholar
5. Braak, H, Del Tredici, K, Rüb, U, et al. Staging of brain pathology related to sporadic Parkinson disease. Neurobiol Aging. 2003;24:197211.CrossRefGoogle Scholar
6. Lang, AE. A critical appraisal of the premotor symptoms of Parkinson disease: potential usefulness in early diagnosis and design of neuroprotective trials. Mov Disord. 2011;26:775–83.Google Scholar
7. Thanvi, B, Threadwell, S. Drug induced parkinsonism: a common cause of parkinsonism in older people. Postgrad Med. 2006;85:322–6.Google Scholar
8. Kim, JS, Youn, J, Shin, H, et al. Nonmotor symptoms in drug-induced parkinsonism and drug-naïve Parkinson disease. Can J Neurol Sci. 2013;40(1)3641.Google Scholar